<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">624</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>TO EVALUATE THE EFFICACY OF ANTHRALIN WITH AND WITHOUT COALTAR IN SHORT CONTACT THERAPY OF MILD TO MODERATE PSORIASIS- A RANDOMIZED DOUBLE BLIND CONTROLLED STUDY&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>M.</surname><given-names>Veena R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>C.</surname><given-names>Satheesh B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>K.</surname><given-names>Sumathy T.</given-names></name></contrib></contrib-group><volume/><issue/><fpage>68</fpage><lpage>71</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Background: Anthralin and coal tar, since their introduction in the treatment of psoriasis have remained one of the main modalities of treatment despite fluctuation. The principle of giving both treatments together is of course not new as the Ingram regime includes both tar baths and anthralin. It has been shown that short contact therapy with the combination of anthralin and coal tar is effective in chronic plaque psoriasis.However, clinical evidence suggested that the addition of coal tar to reduce the irritation and pigmentaion due to anthralin resulted in a compromised efficacy of combinations. The antipsoriatic effect of coal tar itself is low but is boosted when combined with anthralin.&#13;
Objectives: To evaluate whether combining the coal tar with anthralin in short contact therapy in mild to moderate chronic plaque psoriasis compromises the efficacy of combination compared to anthralin alone.&#13;
Methods: Fifty cases having mild to moderate psoriasis were studied in a double blind randomized controlled study. Twenty five patients in group A were treated with anthralin ointment 0.5% and twenty five patients in group B were treated with combination of coal tar 5% and anthralin. Results were analyzed using PASI scores.&#13;
Results: P values at the end of 1st visit, 2nd visit in both the groups Group A and Group B were significant. There was also significant decrease in the PASI score in the patients treated with the combination of anthralin plus coal tar than anthralin alone (P__ampersandsignlt;0.001)&#13;
Conclusion: This study demonstrates that the addition of 5% Coal tar to Anthralin regimen (0.05%) in the treatment of mild to moderate chronic plaque psoriasis did not impair the antipsoriatic effect of the combination and also increased the efficacy of the combination.&#13;
</p></abstract><kwd-group><kwd>Psoriasis</kwd><kwd> Anthralin</kwd><kwd> Dithranol</kwd><kwd> Coal tar</kwd><kwd> Short contact therapy</kwd><kwd> Combination therapy</kwd></kwd-group></article-meta></front></article>
